Elicio Therapeutics Statistics
Total Valuation
ELTX has a market cap or net worth of $75.91 million. The enterprise value is $75.68 million.
Important Dates
The next estimated earnings date is Thursday, August 6, 2026, after market close.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ELTX has 19.07 million shares outstanding. The number of shares has increased by 29.18% in one year.
| Current Share Class | 19.07M |
| Shares Outstanding | 19.07M |
| Shares Change (YoY) | +29.18% |
| Shares Change (QoQ) | +17.44% |
| Owned by Insiders (%) | 29.79% |
| Owned by Institutions (%) | 15.72% |
| Float | 13.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.24
| Current Ratio | 2.24 |
| Quick Ratio | 2.07 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -27.55 |
Financial Efficiency
Return on equity (ROE) is -1,076.34% and return on invested capital (ROIC) is -170.21%.
| Return on Equity (ROE) | -1,076.34% |
| Return on Assets (ROA) | -92.41% |
| Return on Invested Capital (ROIC) | -170.21% |
| Return on Capital Employed (ROCE) | -243.08% |
| Weighted Average Cost of Capital (WACC) | 11.41% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.22M |
| Employee Count | 33 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.12% in the last 52 weeks. The beta is 1.44, so ELTX's price volatility has been higher than the market average.
| Beta (5Y) | 1.44 |
| 52-Week Price Change | -50.12% |
| 50-Day Moving Average | 10.15 |
| 200-Day Moving Average | 9.76 |
| Relative Strength Index (RSI) | 33.27 |
| Average Volume (20 Days) | 3,940,363 |
Short Selling Information
The latest short interest is 1.95 million, so 10.23% of the outstanding shares have been sold short.
| Short Interest | 1.95M |
| Short Previous Month | 1.90M |
| Short % of Shares Out | 10.23% |
| Short % of Float | 14.57% |
| Short Ratio (days to cover) | 3.63 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -37.58M |
| Pretax Income | -40.19M |
| Net Income | -40.19M |
| EBITDA | -37.38M |
| EBIT | -37.58M |
| Earnings Per Share (EPS) | -$2.42 |
Full Income StatementBalance Sheet
The company has $14.95 million in cash and $14.34 million in debt, giving a net cash position of $608,000 or $0.03 per share.
| Cash & Cash Equivalents | 14.95M |
| Total Debt | 14.34M |
| Net Cash | 608,000 |
| Net Cash Per Share | $0.03 |
| Equity (Book Value) | -1.44M |
| Book Value Per Share | -0.08 |
| Working Capital | 8.97M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$38.48 million and capital expenditures -$16,000, giving a free cash flow of -$38.49 million.
| Operating Cash Flow | -38.48M |
| Capital Expenditures | -16,000 |
| Depreciation & Amortization | 197,000 |
| Net Borrowing | 9.87M |
| Free Cash Flow | -38.49M |
| FCF Per Share | -$2.02 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |